[1] Beyer DC, Puente F, Rogers KL, et al.  Prostate brachytherapy: comparison of dose distribution with different 125I source designs[J]. Radiology, 2001, 221(3): 623-627.   doi: 10.1148/radiol.2213010130
[2] Ankem MK, De Carvalho VS, Harangozo AM, et al.  Implications of radioactive seed migration to the lungs after prostate brachytherapy[J]. Urology, 2002, 59(4): 555-559.   doi: 10.1016/S0090-4295(01)01660-0
[3] Raben A, Mychalczak B.  Brachytherapy for non-small cell lung cancer and selected neoplasms of the chest[J]. Chest, 1997, 112(4 Suppl): 276S-286S.
[4] 柴树德, 郑广钧, 毛玉权, 等.  CT引导下经皮穿刺种植放射性125I粒子治疗晚期肺癌[J]. 中华放射肿瘤学杂志, 2004, 13(4): 291-293.   doi: 10.3760/j.issn:1004-4221.2004.04.013
[5] 车剑, 赵铁军.  125I籽源组织间植人治疗恶性肿瘤的疗效分析[J]. 中国现代医药杂志, 2008, 10(8): 47-48.
[6] Finkelstein DM, Ettinger DS, Ruckdeschel JC.  Long-term survivors in metastatic non-small-cell lung cancer: an eastern cooperative oncology group study[J]. J Clin Oncol, 1986, 4(5): 702-709.   doi: 10.1200/JCO.1986.4.5.702